Riabni Prices, Coupons, Copay Cards & Patient Assistance
Riabni (rituximab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Chronic Lymphocytic Leukemia, Follicular Lymphoma, Granulomatosis with Polyangiitis, and others.
Riabni prices
Intravenous Solution
arrx 10 mg/mL Riabni intravenous solution from $775.20 for 10 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 10 milliliters | $77.52 | $775.20 |
| 50 milliliters | $76.72 | $3,835.99 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Riabni Coupons, Copay Cards and Rebates
Riabni offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Riabni Amgen SupportPlus Co-Pay Program
Eligible commercially insured patients may pay as little as $0 per dose up to an annual maximum benefit per calendar year.
- Applies to:
- Riabni
- Number of uses:
- Per prescription per calendar year
Form more information phone: 866-264-2778 or Visit website
Riabni Amgen SupportPlus Co-Pay Program Rebate
Eligible commercially insured patients who have already paid for treatment may request a rebate check in connection with this offer.
- Applies to:
- Riabni
- Number of uses:
- One rebate per prescription fill
Form more information phone: 866-264-2778 or Visit website
Patient Assistance & Copay Programs for Riabni
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Riabni (rituximab-arrx) Injection; IV
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Riabni (rituximab-ARRX) Injection; IV
More information please phone: 866-316-7263 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Ruxience
Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
More about Riabni (rituximab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Riabni drug information
- Riabni (Rituximab Intravenous) (Advanced Reading)
- Riabni (Rituximab-arrx Intravenous) (Advanced Reading)